Generic Name
Zonisamide
Brand Names
Zonegran, Zonisade
FDA approval date: March 27, 2000
Classification: Anti-epileptic Agent
Form: Suspension, Capsule
What is Zonegran (Zonisamide)?
ZONEGRAN is indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy.
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
Efficacy and Safety of Zonisamide as a First Add-On Treatment in Focal Epileptic Seizures or Secondary Generalized Tonic-Clonic Seizures: A Clinical Study
Summary: This study primarily aims to assess the efficacy and safety of zonisamide when used as an adjunctive therapy for focal epilepsy. The main questions it aims to answer are: 1. Does the frequency of epileptic seizures decrease after oral zonisamide， and does it improve cognitive function? 2. Are there any treatment-emergent adverse events associated with oral administration of zonisamide?